ATE230414T1 - Mimetika von beta-faltblatt und verfahren zur verwendung davon - Google Patents
Mimetika von beta-faltblatt und verfahren zur verwendung davonInfo
- Publication number
- ATE230414T1 ATE230414T1 AT98908551T AT98908551T ATE230414T1 AT E230414 T1 ATE230414 T1 AT E230414T1 AT 98908551 T AT98908551 T AT 98908551T AT 98908551 T AT98908551 T AT 98908551T AT E230414 T1 ATE230414 T1 AT E230414T1
- Authority
- AT
- Austria
- Prior art keywords
- beta
- protein
- sheet mimetics
- beta sheet
- sheet
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 108091005804 Peptidases Proteins 0.000 abstract 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 2
- 102000040945 Transcription factor Human genes 0.000 abstract 2
- 108091023040 Transcription factor Proteins 0.000 abstract 2
- 230000003993 interaction Effects 0.000 abstract 2
- 239000004365 Protease Substances 0.000 abstract 1
- 102000001253 Protein Kinase Human genes 0.000 abstract 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229940043355 kinase inhibitor Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 abstract 1
- 108060006633 protein kinase Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1998/002891 WO1999041276A1 (en) | 1998-02-12 | 1998-02-12 | β-SHEET MIMETICS AND METHODS RELATING TO THE USE THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE230414T1 true ATE230414T1 (de) | 2003-01-15 |
Family
ID=22266392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98908551T ATE230414T1 (de) | 1998-02-12 | 1998-02-12 | Mimetika von beta-faltblatt und verfahren zur verwendung davon |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1053246B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002503674A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20010040939A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE230414T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU748887B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2319766A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE69810513T2 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2192764T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999041276A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003525294A (ja) * | 2000-02-29 | 2003-08-26 | ブリストル−マイヤーズ スクイブ ファーマ カンパニー | Ｃ型肝炎ウイルスｎｓ３プロテアーゼの阻害剤 |
| US6534651B2 (en) | 2000-04-06 | 2003-03-18 | Inotek Pharmaceuticals Corp. | 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof |
| US20060276497A1 (en) | 2000-05-09 | 2006-12-07 | Cephalon, Inc. | Novel multicyclic compounds and the use thereof |
| US7122679B2 (en) | 2000-05-09 | 2006-10-17 | Cephalon, Inc. | Multicyclic compounds and the use thereof |
| CN1642550A (zh) * | 2002-02-14 | 2005-07-20 | 美瑞德生物工程公司 | β－折叠模拟物和组合物及其有关方法 |
| JP2011525927A (ja) * | 2008-06-25 | 2011-09-29 | シェーリング コーポレイション | 複素環式抗菌剤の合成および使用 |
| BR112017006920A8 (pt) | 2014-10-06 | 2023-03-07 | Quince Therapeutics Inc | Inibidores de lisina gingipaína |
| EP3374352A4 (en) | 2015-11-09 | 2019-10-02 | Cortexyme, Inc. | GINGIPAINE ARGININE INHIBITORS |
| PL3486242T3 (pl) | 2016-08-31 | 2022-03-21 | Jiangsu Hengrui Medicine Co. Ltd. | Pochodna oksopikolinamidu, sposób jej wytwarzania i zastosowanie farmaceutyczne |
| MX2019003087A (es) | 2016-09-16 | 2019-08-12 | Cortexyme Inc | Inhibidores cetónicos de gingipain de lisina. |
| EP3822264A4 (en) | 2018-07-02 | 2021-11-10 | Jiangsu Hengrui Medicine Co., Ltd. | CRYSTALLINE FORMS OF AN OXYPYRIDINE AMIDE DERIVATIVE AND THEIR PREPARATION PROCESS |
| WO2021057818A1 (zh) | 2019-09-27 | 2021-04-01 | 深圳信立泰药业股份有限公司 | FXIa抑制剂及其制备方法和医药用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2117123T3 (es) * | 1992-02-14 | 1998-08-01 | Merrell Pharma Inc | Derivados de aminocetilmercaptoacetilamida utilizados como inhibidores de la encefalinasa y del enzima de conversion de angiotensina. |
| ES2138622T3 (es) * | 1992-05-15 | 2000-01-16 | Merrell Pharma Inc | Derivados de mercaptoacetilamido piridazo(1,2-a)(1,2)diazepina utilizados como inhibidores de encefalinasa y eca. |
| EP0618223A3 (en) * | 1993-03-08 | 1996-06-12 | Sandoz Ltd | Peptides, the release of Interleukin 1-Bêta, useful as anti-inflammatory agents. |
| SK83897A3 (en) * | 1994-12-22 | 1998-05-06 | Iaf Biochem Int | Low molecular weight bicyclic thrombin inhibitors |
| EP0815123B1 (en) * | 1995-03-24 | 2001-10-04 | Molecumetics, Ltd. | Beta-sheet mimetics and use thereof as protease inhibitors |
| WO1996030396A1 (en) * | 1995-03-24 | 1996-10-03 | Molecumetics Ltd. | β-SHEET MIMETICS AND USE THEREOF AS PROTEASE INHIBITORS |
| US5877313A (en) * | 1995-05-17 | 1999-03-02 | Bristol-Myers Squibb | Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP |
| IT1277405B1 (it) * | 1995-08-01 | 1997-11-10 | Menarini Farma Ind | Derivati di lattami biciclici come inibitori della trombina |
| WO1998005333A1 (en) * | 1996-08-05 | 1998-02-12 | Molecumetics Ltd. | Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
-
1998
- 1998-02-12 AU AU66557/98A patent/AU748887B2/en not_active Ceased
- 1998-02-12 ES ES98908551T patent/ES2192764T3/es not_active Expired - Lifetime
- 1998-02-12 KR KR1020007008856A patent/KR20010040939A/ko not_active Ceased
- 1998-02-12 CA CA002319766A patent/CA2319766A1/en not_active Abandoned
- 1998-02-12 WO PCT/US1998/002891 patent/WO1999041276A1/en not_active Ceased
- 1998-02-12 EP EP98908551A patent/EP1053246B1/en not_active Expired - Lifetime
- 1998-02-12 AT AT98908551T patent/ATE230414T1/de not_active IP Right Cessation
- 1998-02-12 JP JP2000531467A patent/JP2002503674A/ja active Pending
- 1998-02-12 DE DE69810513T patent/DE69810513T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1053246A1 (en) | 2000-11-22 |
| DE69810513T2 (de) | 2004-03-18 |
| AU6655798A (en) | 1999-08-30 |
| JP2002503674A (ja) | 2002-02-05 |
| CA2319766A1 (en) | 1999-08-19 |
| KR20010040939A (ko) | 2001-05-15 |
| EP1053246B1 (en) | 2003-01-02 |
| DE69810513D1 (de) | 2003-02-06 |
| WO1999041276A1 (en) | 1999-08-19 |
| AU748887B2 (en) | 2002-06-13 |
| ES2192764T3 (es) | 2003-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69735545D1 (de) | Verwendung von beta-blatt mimetika als protease und kinase hemmer und alshemmer eines transkriptionsfaktors | |
| DE602004014117D1 (de) | Thiazole zur verwendung als inhibitoren von protein-kinasen | |
| ATE269295T1 (de) | Btk inhibitoren und verfahren zur identifizierung und verwendung | |
| ZA99133B (en) | Transgenic rabbit that expresses a functional human lipoprotein (A). | |
| ATE211129T1 (de) | Inhibitoren von beta-amyloid-protein-herstellung | |
| ATE450530T1 (de) | Zusammensetzungen zur verwendung als protein- kinase-inhibitoren | |
| EP1140840A4 (en) | -G (V) -CARBOXYARYL SUBSTITUTED DIPHENYL UREASINE AS RAF KINASE INHIBITORS | |
| DE60023936D1 (de) | Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen | |
| MY140132A (en) | Thiazolidin-4-one derivatives for use in the treatment of anemias | |
| DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| DE60007095D1 (de) | Calanolide zur hemmung von btk | |
| ATE230414T1 (de) | Mimetika von beta-faltblatt und verfahren zur verwendung davon | |
| ATE521357T1 (de) | Verfahren zur behandlung von hepatitis | |
| CY1107640T1 (el) | Μεθοδος για πιστοποιηση παραγοντων για τη θεραπεια διαβητη | |
| DE60323994D1 (de) | Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan | |
| DE60016405D1 (de) | Neurodegenerative-erkrankung verwandtes gen | |
| DE60024997D1 (de) | Vgf polypeptide und verfahren zur behandlung von vgf-erkrankungen | |
| TW200700089A (en) | Recombinant protein comprising starch binding domain and use thereof | |
| DE602006009901D1 (de) | Verfahren zur herstellung von 7-ethyl-10-hydroxycamptothecin | |
| ATE267194T1 (de) | Medikamente geeignet zur behandlung von proliferativen erkrankungen | |
| MXPA05009428A (es) | Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas. | |
| NZ505980A (en) | Beta-sheet mimetics | |
| ATE364180T1 (de) | Screeningverfahren mit bnpi und dnpi | |
| DE69521281D1 (de) | Verfahren zur Herstellung von menschlichem oder humanem Matrilysin mittels rekombinanter DNA. | |
| DE60226126D1 (de) | Verwendung von gamma-gt inhibitoren zur behandlung von chronischen degenerativerkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |